DR. EMILY ZARUHI TOULOUKIAN D.O. NPI 1053577718

NPI Information

  • NPI: 1053577718
  • Provider Name: DR. EMILY ZARUHI TOULOUKIAN, D.O.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 8121 ROURK ST
    MYRTLE BEACH, SC
    ZIP 29572
  • Phone: (843) 692-5000

Map and Directions

Get Directions

NPI Details

DR. Emily Zaruhi Touloukian, D.O. is a hematology and oncology internal medicine in Myrtle Beach, SC with 19 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Emily Zaruhi Touloukian, D.O. NPI is 1053577718. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

8121 ROURK ST
MYRTLE BEACH, SC
ZIP 29572-128
Phone: (843) 692-5000

The NPI 1053577718 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, ferric derisomaltose, 10 mg (HCPCS:J1437)
  • Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood creatinine level (HCPCS:82565)
  • Liver function blood test panel (HCPCS:80076)
  • Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Calcium level, total (HCPCS:82310)
  • Blood chloride level (HCPCS:82435)
  • Blood sodium level (HCPCS:84295)
  • Uric acid level, blood (HCPCS:84550)
  • Phosphate level (HCPCS:84100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Unclassified drugs (HCPCS:J3490)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Magnesium level (HCPCS:83735)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Blood test, clotting time (HCPCS:85610)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Blood potassium level (HCPCS:84132)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month (HCPCS:99491)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Urinalysis, manual test (HCPCS:81002)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Folic acid level, serum (HCPCS:82746)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • X-ray of chest, 2 views (HCPCS:71046)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Ct scan of chest without contrast (HCPCS:71250)

The enumeration date for this NPI number is 8/1/2008 and was last updated on 1/11/2013.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology1628SOUTH CAROLINAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.